$HAL
HALLIBURTON CO

2023 Q4 Form 10-Q Financial Statement

#000004501223000056 Filed on October 25, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $5.739B $5.804B
YoY Change 2.81% 8.34%
Cost Of Revenue $4.606B $4.686B
YoY Change -540.34% -616.08%
Gross Profit $1.133B $1.118B
YoY Change -82.91% -82.15%
Gross Profit Margin 19.74% 19.26%
Selling, General & Admin $60.00M $58.00M
YoY Change -3.23% -1.69%
% of Gross Profit 5.3% 5.19%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $256.0M $256.0M
YoY Change 8.47% 9.4%
% of Gross Profit 22.59% 22.9%
Operating Expenses $4.681B $81.00M
YoY Change -17.18% -98.51%
Operating Profit -$3.548B $1.037B
YoY Change -463.52% 22.58%
Interest Expense -$207.0M -$93.00M
YoY Change 179.73% 0.0%
% of Operating Profit -8.97%
Other Income/Expense, Net -$16.00M -$28.00M
YoY Change -73.33% -41.67%
Pretax Income $835.0M $916.0M
YoY Change -0.83% 29.93%
Income Tax $168.0M $192.0M
% Of Pretax Income 20.12% 20.96%
Net Earnings $661.0M $716.0M
YoY Change 0.76% 31.62%
Net Earnings / Revenue 11.52% 12.34%
Basic Earnings Per Share $800.0K
Diluted Earnings Per Share $0.74 $790.0K
COMMON SHARES
Basic Shares Outstanding 895.1M shares 898.5M shares
Diluted Shares Outstanding 902.0M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.264B $2.036B
YoY Change -3.5% 2.98%
Cash & Equivalents $2.264B $2.036B
Short-Term Investments
Other Short-Term Assets $1.193B $1.104B
YoY Change 12.97% 12.88%
Inventory $3.226B $3.336B
Prepaid Expenses
Receivables $4.860B $5.124B
Other Receivables $0.00 $0.00
Total Short-Term Assets $11.54B $11.60B
YoY Change 5.4% 11.42%
LONG-TERM ASSETS
Property, Plant & Equipment $4.900B $4.733B
YoY Change -6.86% 12.61%
Goodwill $2.850B $2.850B
YoY Change 0.74% 0.78%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $4.302B $1.710B
YoY Change 2.11% 10.97%
Total Long-Term Assets $13.14B $12.84B
YoY Change 6.8% 5.68%
TOTAL ASSETS
Total Short-Term Assets $11.54B $11.60B
Total Long-Term Assets $13.14B $12.84B
Total Assets $24.68B $24.44B
YoY Change 6.14% 8.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.147B $3.238B
YoY Change 0.83% 5.68%
Accrued Expenses $951.0M $1.223B
YoY Change 10.84% 60.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $5.608B $5.419B
YoY Change 4.92% 9.08%
LONG-TERM LIABILITIES
Long-Term Debt $7.636B $7.783B
YoY Change -3.68% -1.82%
Other Long-Term Liabilities $687.0M $790.0M
YoY Change -65.74% 5.76%
Total Long-Term Liabilities $687.0M $790.0M
YoY Change -93.08% 5.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.608B $5.419B
Total Long-Term Liabilities $687.0M $790.0M
Total Liabilities $15.25B $15.25B
YoY Change -0.37% 2.25%
SHAREHOLDERS EQUITY
Retained Earnings $12.54B $12.02B
YoY Change 18.58% 19.89%
Common Stock $2.726B $2.689B
YoY Change 0.44% -0.26%
Preferred Stock
YoY Change
Treasury Stock (at cost) $5.540B $5.330B
YoY Change 8.46% 8.38%
Treasury Stock Shares
Shareholders Equity $9.391B $9.150B
YoY Change
Total Liabilities & Shareholders Equity $24.68B $24.44B
YoY Change 6.14% 8.33%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $661.0M $716.0M
YoY Change 0.76% 31.62%
Depreciation, Depletion And Amortization $256.0M $256.0M
YoY Change 8.47% 9.4%
Cash From Operating Activities $1.410B $874.0M
YoY Change 21.24% 16.07%
INVESTING ACTIVITIES
Capital Expenditures $399.0M $409.0M
YoY Change -214.0% -262.95%
Acquisitions
YoY Change
Other Investing Activities -$136.0M -$19.00M
YoY Change 248.72% -190.48%
Cash From Investing Activities -$535.0M -$428.0M
YoY Change 37.53% 86.09%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -544.0M -483.0M
YoY Change 58.6% -32.16%
NET CHANGE
Cash From Operating Activities 1.410B 874.0M
Cash From Investing Activities -535.0M -428.0M
Cash From Financing Activities -544.0M -483.0M
Net Change In Cash 331.0M -37.00M
YoY Change -23.2% -80.42%
FREE CASH FLOW
Cash From Operating Activities $1.410B $874.0M
Capital Expenditures $399.0M $409.0M
Free Cash Flow $1.011B $465.0M
YoY Change -33.18% -53.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
hal Gain Loss On Blue Chip Swap Transaction
GainLossOnBlueChipSwapTransaction
-104000000 usd
hal Gain Loss On Blue Chip Swap Transaction
GainLossOnBlueChipSwapTransaction
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-42000000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-48000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-129000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-120000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
916000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
705000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2528000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1268000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
156000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
533000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
338000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
724000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
549000000 usd
us-gaap Profit Loss
ProfitLoss
1995000000 usd
us-gaap Profit Loss
ProfitLoss
930000000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8000000 usd
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
5000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
18000000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
14000000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
716000000 usd
us-gaap Net Income Loss
NetIncomeLoss
1977000000 usd
us-gaap Net Income Loss
NetIncomeLoss
916000000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
800000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
600000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2190000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1010000.00
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
790000
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
600000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2190000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1010000.00
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
898000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
908000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
901000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
904000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
902000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
910000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
904000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
907000000 shares
CY2023Q3 us-gaap Profit Loss
ProfitLoss
724000000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
549000000 usd
us-gaap Profit Loss
ProfitLoss
1995000000 usd
us-gaap Profit Loss
ProfitLoss
930000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
3000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
547000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
541000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1980000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
917000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036000000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2346000000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
718000000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
731000000 usd
CY2023Q3 us-gaap Receivables Net Current
ReceivablesNetCurrent
5124000000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4627000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3336000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2923000000 usd
CY2023Q3 us-gaap Other Assets Current
OtherAssetsCurrent
1104000000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
1056000000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
11600000000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
10952000000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11891000000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11660000000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4733000000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4348000000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
2850000000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
2829000000 usd
CY2023Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2517000000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
2636000000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1032000000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
913000000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1710000000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1577000000 usd
CY2023Q3 us-gaap Assets
Assets
24442000000 usd
CY2022Q4 us-gaap Assets
Assets
23255000000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3238000000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3121000000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
643000000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
634000000 usd
CY2023Q3 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
332000000 usd
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
349000000 usd
CY2023Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
266000000 usd
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
294000000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
248000000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
224000000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
692000000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
723000000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
5419000000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5345000000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
869000000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
791000000 usd
CY2023Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
392000000 usd
CY2022Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
408000000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
790000000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
15253000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
15278000000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
2.50
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2000000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1065000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1066000000 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
2663000000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
2664000000 usd
CY2023Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
26000000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
50000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-227000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-230000000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
12018000000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
10572000000 usd
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
5330000000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
5108000000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
9150000000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7948000000 usd
CY2023Q3 us-gaap Minority Interest
MinorityInterest
39000000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
29000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9189000000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7977000000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24442000000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23255000000 usd
us-gaap Profit Loss
ProfitLoss
1995000000 usd
us-gaap Profit Loss
ProfitLoss
930000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
742000000 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
301000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
91000000 usd
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
64000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1124000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-578000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
546000000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
46000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
433000000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
327000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
150000000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
1242000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1268000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
705000000 usd
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.222
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
533000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2500000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.211
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
338000000 usd
CY2023Q3 hal Gain Loss On Blue Chip Swap Transaction
GainLossOnBlueChipSwapTransaction
0 usd
CY2022Q3 hal Gain Loss On Blue Chip Swap Transaction
GainLossOnBlueChipSwapTransaction
0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
544000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
725000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
1998000000 usd
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
932000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8000000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
6000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
18000000 usd
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
15000000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
717000000 usd
CY2023Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7783000000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7928000000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
806000000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
170000000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
164000000 shares
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
704000000 usd
us-gaap Restructuring Charges
RestructuringCharges
0 usd
us-gaap Restructuring Charges
RestructuringCharges
366000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1153000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
413000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
561000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
137000000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
807000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
14000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
136000000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
157000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
112000000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2000000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
160000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1127000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1455000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-107000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-113000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-310000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1067000000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2346000000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3044000000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2036000000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1977000000 usd
us-gaap Interest Paid Net
InterestPaidNet
355000000 usd
us-gaap Interest Paid Net
InterestPaidNet
384000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
528000000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
276000000 usd
us-gaap Basis Of Accounting
BasisOfAccounting
Basis of Presentation<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements were prepared using generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Regulation S-X. Accordingly, these financial statements do not include all information or notes required by generally accepted accounting principles for annual financial statements and should be read together with our 2022 Annual Report on Form 10-K.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our accounting policies are in accordance with United States generally accepted accounting principles. The preparation of financial statements in conformity with these accounting principles requires us to make estimates and assumptions that affect:</span></div><div style="margin-bottom:3pt;padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements; and</span></div><div style="padding-left:49.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">•</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10pt">the reported amounts of revenue and expenses during the reporting period.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ultimate results could differ from our estimates.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In our opinion, the condensed consolidated financial statements included herein contain all adjustments necessary to present fairly our financial position as of September 30, 2023 and the results of our operations for the three and nine months ended September 30, 2023 and 2022, and our cash flows for the nine months ended September 30, 2023 and 2022. Such adjustments are of a normal recurring nature. In addition, certain reclassifications of prior period balances have been made to conform to the current period presentation.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of our operations for the three and nine months ended September 30, 2023 may not be indicative of results for the full year.</span></div>
CY2023Q3 hal Number Of Business Segments
NumberOfBusinessSegments
2 division
CY2023Q3 hal Number Of Business Segments
NumberOfBusinessSegments
2 division
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5804000000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5357000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17279000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14715000000 usd
CY2023Q3 hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
23000000 usd
CY2022Q3 hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
0 usd
hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
36000000 usd
hal Saps4 Upgrade Expense
SAPS4UpgradeExpense
0 usd
CY2023Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
CY2022Q3 us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
0 usd
us-gaap Restructuring Settlement And Impairment Provisions
RestructuringSettlementAndImpairmentProvisions
366000000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
1037000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
846000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3025000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1731000000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-93000000 usd
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-93000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-264000000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-301000000 usd
CY2023Q3 hal Gain Loss On Blue Chip Swap Transaction
GainLossOnBlueChipSwapTransaction
0 usd
CY2022Q3 hal Gain Loss On Blue Chip Swap Transaction
GainLossOnBlueChipSwapTransaction
0 usd
hal Gain Loss On Blue Chip Swap Transaction
GainLossOnBlueChipSwapTransaction
-104000000 usd
hal Gain Loss On Blue Chip Swap Transaction
GainLossOnBlueChipSwapTransaction
0 usd
CY2023Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2022Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-42000000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28000000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-48000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-129000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-120000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
916000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
705000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2528000000 usd
hal Gain Loss On Blue Chip Swap Transaction
GainLossOnBlueChipSwapTransaction
-104000000 usd
CY2023Q3 hal Number Of Business Segments
NumberOfBusinessSegments
2 division
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5804000000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5804000000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5357000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
17279000000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14715000000 usd
us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
one year
CY2023Q3 hal Number Of Customers Exceed Receivables Threshold
NumberOfCustomersExceedReceivablesThreshold
0 customers
CY2022Q4 hal Number Of Customers Exceed Receivables Threshold
NumberOfCustomersExceedReceivablesThreshold
0 customers
CY2023Q3 hal Maximum Percentage Gross Trade Receivables From One Customer
MaximumPercentageGrossTradeReceivablesFromOneCustomer
0.10
CY2022Q4 hal Maximum Percentage Gross Trade Receivables From One Customer
MaximumPercentageGrossTradeReceivablesFromOneCustomer
0.10
CY2023Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
2100000000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
1859000000 usd
CY2023Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
1099000000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
953000000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
137000000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
111000000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
3336000000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
2923000000 usd
CY2023Q3 hal Outstanding Supplier Finance Payment Obligation
OutstandingSupplierFinancePaymentObligation
320000000 usd
CY2022Q4 hal Outstanding Supplier Finance Payment Obligation
OutstandingSupplierFinancePaymentObligation
273000000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
192000000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
916000000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
156000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1300000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.266
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7977000000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
655000000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
145000000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
100000000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
60000000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
3000000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8445000000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
616000000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
144000000 usd
CY2023Q2 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
250000000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
61000000 usd
CY2023Q2 us-gaap Stockholders Equity Other
StockholdersEquityOther
2000000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
8727000000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
724000000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1000000 usd
CY2023Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2023Q3 us-gaap Dividends Common Stock
DividendsCommonStock
144000000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
200000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
84000000 usd
CY2023Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
3000000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
9189000000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
6728000000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
264000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
5000000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
108000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
144000000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7033000000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
117000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.12
CY2022Q2 us-gaap Dividends Common Stock
DividendsCommonStock
109000000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
59000000 usd
CY2022Q3 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1000000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7645000000 usd
us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
5100000 shares
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
4300000000 usd
CY2023Q3 hal Treasury Stock Shares Acquired From Inception
TreasuryStockSharesAcquiredFromInception
247000000 shares
CY2023Q3 hal Treasury Stock Value Acquired Cost Method From Inception
TreasuryStockValueAcquiredCostMethodFromInception
9800000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-83000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-84000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
102000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Defined Benefit Pension And Other Postretirement Plans Net Of Tax
AccumulatedOtherComprehensiveIncomeLossDefinedBenefitPensionAndOtherPostretirementPlansNetOfTax
101000000 usd
CY2023Q3 hal Accumulated Other Comprehensive Income Loss Other Net Of Tax
AccumulatedOtherComprehensiveIncomeLossOtherNetOfTax
-42000000 usd
CY2022Q4 hal Accumulated Other Comprehensive Income Loss Other Net Of Tax
AccumulatedOtherComprehensiveIncomeLossOtherNetOfTax
-45000000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-227000000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-230000000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
898000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
908000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
901000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
904000000 shares
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4000000 shares
CY2022Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
3000000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
902000000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
910000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
904000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
907000000 shares
hal Numberofdaysfromperiodend
Numberofdaysfromperiodend
P2D
hal Numberofdaysfromperiodend
Numberofdaysfromperiodend
P2D

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
hal-20230930_lab.xml Edgar Link unprocessable
0000045012-23-000056-index-headers.html Edgar Link pending
0000045012-23-000056-index.html Edgar Link pending
0000045012-23-000056.txt Edgar Link pending
0000045012-23-000056-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hal-20230930.htm Edgar Link pending
hal-20230930.xsd Edgar Link pending
hal-20230930_g1.jpg Edgar Link pending
hal-20230930_g2.jpg Edgar Link pending
hal-20230930_cal.xml Edgar Link unprocessable
hal-20230930_def.xml Edgar Link unprocessable
hal-20230930_g3.jpg Edgar Link pending
hal_09302023-ex311.htm Edgar Link pending
hal_09302023-ex312.htm Edgar Link pending
hal_09302023-ex321.htm Edgar Link pending
hal_09302023-ex322.htm Edgar Link pending
hal_09302023-ex95.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
hal-20230930_pre.xml Edgar Link unprocessable
hal-20230930_htm.xml Edgar Link completed